Gowling WLG advised AstraZeneca on the agreement. Cooley LLP advised Quell Therapeutics. A collaboration and license agreement has been established between AstraZeneca and biopharmaceutical company Quell...
AstraZeneca’s Collaboration with Quell Therapeutics
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
AstraZeneca’s Agreement with Scorpion Therapeutics
Gowling WLG advised AstraZeneca on the transaction. AstraZeneca started a collaboration with Scorpion Therapeutics, Inc. (“Scorpion”) to develop precision medicines against previously hard-to-target cancer proteins. Scorpion will...
AstraZeneca v. Mylan Pharmaceuticals Inc.
Williams & Connolly LLP advised AstraZeneca on the deal. AstraZeneca obtained a trial victory in a high-stakes Hatch-Waxman patent litigation against Mylan Pharmaceuticals Inc. involving three patents covering...
AstraZeneca’s Strategic Collaboration With Junshi Biosciences
Sidley Austin LLP advised AstraZeneca China on the deal. AstraZeneca China announced a strategic collaboration with Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences). AstraZeneca China will be...